Transsion is a consumer company

Health supplements seller Health and Happiness (H&H) International Holdings Ltd. (1112.HK) said on Sunday that its revenue grew by double-digits on a like-for-like basis in the first half of 2026, mainly driven by growth across its three major business segments: adult nutrition and care, baby nutrition and care, and pet nutrition and care.

The company expects to report its adjusted net profit for the six-month period to more than double from a year earlier. Its IFRS net profit grew by more than 700%, mainly due to a low base in the same period last year.

During the period, revenue from its adult nutrition and care segment recorded low- to mid-teens growth, with Mainland China, Australia and New Zealand, and expansion markets in Asia all maintaining double-digit growth. Its Swisse sales on Douyin grew by more than 50%.

Revenue from the baby nutrition and care segment rose by a high double-digit percentage, with infant formula revenue up by more than 50%. Biostime’s market share in Mainland China’s ultra-premium infant formula segment rose to 20%. Revenue from its pet nutrition and care segment recorded mid- to high-single-digit growth.

Shares of H&H International opened higher on Monday and traded at HK$13.56 by the midday break, up 19.79%.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Hesai makes LiDAR

Hesai eyes next big thing with robotics initiatives

The LiDAR technology specialist is jumping on the fast-moving humanoid robot bandwagon with its latest strategic growth initiative Key Takeaways: Hesai has begun generating revenue from robotic actuation modules, while…